| Title | Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome |
| Creator | |
| Date Issued | 2013-10-01 |
| Source Publication | FASEB Journal
 |
| Volume | 27Issue:10Pages:4122-4135 |
| Abstract | Previously, exchange protein directly activated by cAMP 2 (Epac2) and PKA were known to play a role in glucose-stimulated insulin secretion (GSIS) by pancreatic β cells. The present study shows that Epac1 mRNA is also expressed by β cells. Therefore, we generated mice and embryonic stem (ES) cells with deletion of the Epac1 gene to define its role in β-cell biology and metabolism. The homozygous Epac1-knockout (Epac) mice developed impaired glucose tolerance and GSIS with deranged islet cytoarchitecture, which was confirmed by isolated islets from adult Epac1 mice. Moreover, Epac1 mice developed more severe hyperglycemia with increased β-cell apoptosis and insulitis after multiple low-dose streptozotocin (MLDS; 40 mg/kg) treatment than Epac1 mice. Interestingly, Epac1 mice also showed metabolic defects, including increased respiratory exchange ratio (RER) and plasma triglyceride (TG), and more severe diet-induced obesity with insulin resistance, which may contributed to β-cell dysfunction. However, islets differentiated from Epac ES cells showed insulin secretion defect, reduced Glut2 and PDX-1 expression, and abolished GLP-1-stimulated PCNA induction, suggesting a role of Epac1 in β-cell function. The current study provides in vitro and in vivo evidence that Epac1 has an important role in GSIS of β cells and phenotype resembling metabolic syndrome. © FASEB. |
| Keyword | Glucose transporter type 2 Glucose-stimulated insulin secretion High-fat-diet-induced obesity Hyperglycemia Multiple lowdose streptozotocin-induced diabetes |
| DOI | 10.1096/fj.13-230433 |
| URL | View source |
| Language | 英语English |
| Scopus ID | 2-s2.0-84885160578 |
| Citation statistics | |
| Document Type | Journal article |
| Identifier | http://repository.uic.edu.cn/handle/39GCC9TT/6536 |
| Collection | Beijing Normal-Hong Kong Baptist University |
| Corresponding Author | Chung，Sookja K. |
| Affiliation | 1.Department of Anatomy, Faculty of Medicine, University of Hong Kong,21 Sassoon Rd.,Hong Kong,Hong Kong 2.Department of Medicine, University of Hong Kong,Hong Kong,Hong Kong 3.Clinical Biochemistry Unit, University of Hong Kong,Hong Kong,Hong Kong 4.Department of Pharmacology, University of Hong Kong,Hong Kong,Hong Kong 5.Research Centre of Heart, Brain, Hormone, and Healthy Aging, Li Ka Shing Faculty of Medicine, University of Hong Kong,Hong Kong,Hong Kong 6.Forth Military Medical University,Xi'an,China 7.Molecular Cancer Research, Universitair Medisch Centrum Utrecht,Utrecht,Netherlands 8.Division of Science and Technology, United International College,Zhuhai,China |
| Recommended Citation GB/T 7714 | Kai，Alan K.L.,Lam，Amy K.M.,Chen，Yingxianet al. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome[J]. FASEB Journal, 2013, 27(10): 4122-4135. |
| APA | Kai，Alan K.L., Lam，Amy K.M., Chen，Yingxian., Tai，Andrew C.P., Zhang，Xinmei., .. & Chung，Sookja K. (2013). Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB Journal, 27(10), 4122-4135. |
| MLA | Kai，Alan K.L.,et al."Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome". FASEB Journal 27.10(2013): 4122-4135. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
BNBU 
Library
Edit Comment